Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3979021 | 0.95 | CYP1A2 (0.41) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL13697015 | 0.93 | CYP1A2 (0.40) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL13697020 | 0.91 | PIK3CA (0.33) | CYP1A2ALDH1A1HPGDTNFERBB2 | |
| SCHEMBL38662958 | 0.91 | CYP1A2 (0.39) | CYP1A2ALDH1A1 | |
| SCHEMBL13697018 | 0.89 | CYP1A2 (0.40) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL13697004 | 0.89 | CYP1A2 (0.40) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL13697016 | 0.88 | CYP1A2 (0.39) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL13697000 | 0.88 | CYP1A2 (0.39) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL13697011 | 0.87 | CYP1A2 (0.38) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL13697005 | 0.87 | CYP1A2 (0.38) | CYP1A2ALDH1A1HPGDHSD17B10THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090236975-A1 | SILICON-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE UTILIZING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090236975-A1 | SILICON-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE UTILIZING THE SAME | ESPL1, EML4, EED | CYP1A2 3345/4885ALDH1A1 2236/4885HPGD 4582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.